Full name
INSIEME SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.11.Z - Non-specialized retail trade with a predominance of food, beverages, or tobacco products
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
49.41.Z - Road freight transport
73.11.Z - Advertising agency activities
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,6 | -0,6 | -0,1 | 88,3 |
EBITDA | 0,8 | -0,4 | 0,6 | 254,6 |
Short time liabilities | 5,9 | 6,7 | 8,2 | 22 |
Equity capital | 1,7 | 0,7 | 0,6 | -9,1 |
Operating profit (EBIT) | 0,6 | -0,6 | 0,4 | 158,7 |
Assets | 7,8 | 7,9 | 9,3 | 18,8 |
Net profit (loss) | 0,7 | -0,8 | -0,1 | 91,9 |
Cash | 2,3 | 2 | 0,4 | -78,5 |
Net income from sale | 27,3 | 30 | 32,8 | 9,2 |
Liabilities and provisions for liabilities | 6,1 | 7,2 | 8,7 | 21,4 |
Working assets | 6,4 | 6,8 | 8,2 | 20,7 |
Depreciation | 0,2 | 0,2 | 0,3 | 22 |
% | % | % | p.p. | |
Profitability of capital | 40,4 | -112,4 | -10 | 102,4 |
Equity capital to total assets | 22 | 8,5 | 6,5 | -2 |
Gross profit margin | 2,2 | -1,9 | -0,2 | 1,7 |
EBITDA Margin | 3 | -1,4 | 2 | 3,4 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 79 | 82 | 91 | 9 |
Current financial liquidity indicator | 1.0795282125473022 | 1.0038890838623047 | 0.9919204711914062 | 0 |
Net dept to EBITDA | -2.5431041717529297 | 4.616018772125244 | -0.6701062917709351 | -5,3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane